Trial Details
COMPLETEDBasic Information
| Clinical ID | c166 |
|---|---|
| Identifier | NCT00232258 |
| Trial Title | Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Inflammatory Bowel Disease |
| Interventions | DRUG: Nolpitantium besylate |
Participant Information
| Sponsor | Sanofi |
|---|---|
| City | Buenos Aires |
| Country/Region | Argentina |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-05 |
|---|---|
| Primary Completion Date | 2025-09-06 |
| Completion Date | 2025-09-06 |